Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
9 Patents
#93 in Miami, FL
#974 in Florida
#32,627 in US
Opko Pharmaceuticals, LLC
Forward Citations = 32
17 inventors:
Miami, FL, United States of America
Opko Pharmaceuticals, LLC
Calculating rank
% Expired Patents = 66.7
EPO Patents = 4
Forward Citations = 32
Loading Chart...
Loading Chart...
17 inventors (with patents filed for the assignee):
Phillip Frost (6 out of 13 patents)
Arturo Santos (3 out of 3 patents)
Thomas Kodadek (2 out of 12 patents)
4. Jane Hsiao (1 out of 5 patents)
5. Tahir Ahmed (1 out of 9 patents)
6. Arie Gutman (1 out of 1 patent)
7. Irina Fedotev (1 out of 7 patents)
8. Olga Grossman (1 out of 1 patent)
9. Muralidhar Reddy Moola (1 out of 2 patents)
10. Jessica Schilke (1 out of 1 patent)
11. Karina Drumm (1 out of 2 patents)
12. Stefan Hubert Schlör (1 out of 2 patents)
13. Frank Göhring (1 out of 2 patents)
14. Naveed Shams (1 out of 2 patents)
15. Nadine Dejneka (1 out of 2 patents)
9 patents:
Company Overview
Opko Pharmaceuticals, LLC is a multinational biopharmaceutical company that focuses on developing diagnostics and drugs in several therapeutic areas, including ophthalmology, endocrinology, and nephrology. The company's pipeline includes products for the treatment of chronic kidney disease, growth hormone deficiency, and prostate cancer, among others. Opko is committed to improving patient care and advancing medical innovation through research and development.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Opko Pharmaceuticals, LLC. Retrieved from https://idiyas.com/company/opko-pharmaceuticals
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
4 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]